Arrowstreet Capital’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.3M Buy
703,528
+159,755
+29% +$6.76M 0.01% 712
2025
Q4
$25.2M Buy
543,773
+510,060
+1,513% +$21.3M 0.01% 669
2025
Q3
$1.18M Buy
+33,713
New +$1.17M ﹤0.01% 1560
2024
Q4
Sell
-276,731
Closed -$10.7M 1770
2024
Q3
$10.7M Buy
276,731
+203,994
+280% +$7.28M 0.01% 729
2024
Q2
$2.34M Sell
72,737
-205,776
-74% -$7.14M ﹤0.01% 1033
2024
Q1
$10.8M Buy
278,513
+59,165
+27% +$2.07M 0.01% 661
2023
Q4
$6.75M Sell
219,348
-211,195
-49% -$5.29M 0.01% 664
2023
Q3
$9.62M Buy
430,543
+58,339
+16% +$1.33M 0.01% 525
2023
Q2
$8M Buy
372,204
+59,330
+19% +$1.35M 0.01% 550
2023
Q1
$7.51M Buy
+312,874
New +$8.3M 0.01% 604

Other funds holding COLL